Professional Summary

Professional Overview

Gary Hammer is a visionary leader and accomplished physician-scientist who has dedicated his career to advancing the field of therapeutics. As the Founder and member of the Board of Directors at Sling Therapeutics, he leverages his extensive expertise in endocrinology and healthcare innovation to drive the development of groundbreaking treatments.

Experience Summary

Current Role

As the Founder and Board of Directors member at Sling Therapeutics (formerly Vasaragen), Gary plays a pivotal role in shaping the company's strategic direction and overseeing the development of its novel therapeutic solutions. He is responsible for leading the company's research and innovation efforts, fostering collaborative partnerships, and ensuring the seamless execution of the organization's long-term growth objectives.

Career Progression

Prior to founding Sling Therapeutics, Gary served as a professor-physician-scientist at the University of Michigan, where he has held this position since 1999. He also co-founded MILLENDO THERAPEUTICS, a biopharmaceutical company focused on developing treatments for endocrine-related diseases, and served as a key member of the leadership team from 2012 to 2021.

Earlier in his career, Gary completed his postdoctoral fellowship and endocrinology fellowship at the University of California, San Francisco, where he honed his expertise in endocrinology and laid the foundation for his successful research and clinical practice.

Academic Background

Gary holds a distinguished academic background, having earned his medical degree and completed his residency in internal medicine at the University of California, San Francisco.

Areas of Expertise

Gary's expertise spans a wide range of disciplines, including endocrinology, healthcare innovation, and strategic leadership. He is recognized for his deep understanding of the complex challenges facing the pharmaceutical industry and his ability to devise innovative solutions that address unmet medical needs. As a seasoned physician-scientist, he possesses a unique blend of clinical, research, and entrepreneurial acumen, enabling him to drive transformative change within the healthcare landscape.

Professional Impact

Throughout his career, Gary has made significant contributions to the field of endocrinology and the development of novel therapeutics. His groundbreaking research and clinical work have led to the advancement of several promising treatment options, positively impacting the lives of patients worldwide. As the Founder and Board of Directors member at Sling Therapeutics, Gary continues to push the boundaries of medical innovation, committed to developing transformative solutions that will redefine the standard of care.

Conclusion

Gary Hammer's distinguished career and unwavering commitment to advancing the field of therapeutics make him a respected leader and a valuable asset to the healthcare industry. With his exceptional expertise, visionary mindset, and track record of success, he is poised to continue driving impactful change and positioning Sling Therapeutics as a trailblazer in the development of cutting-edge treatments.